These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 828345)

  • 1. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.
    Bartter FC; Gill JR; Frolich JC; Bowden RE; Hollifield JW; Radfar N; Keiser HR; Oates JA; Seyberth H; Taylor AA
    Trans Assoc Am Physicians; 1976; 89():77-91. PubMed ID: 828345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of chloride transport in the thick ascending limb in the pathogenesis of Bartter's syndrome.
    Gill JR
    Klin Wochenschr; 1982 Oct; 60(19):1212-4. PubMed ID: 6755050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bartter's syndrome.
    Bartter FC
    Urol Clin North Am; 1977 Jun; 4(2):253-61. PubMed ID: 331616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
    Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS; Chen WY; Yen TS; Lai MS
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
    Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
    Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case with Bartter's syndrome associated with type II hyperlipidemia, increased fluidity of plasma VLDL and abnormal configuration of peripheral erythrocytes (author's transl)].
    Imai T; Makino K; Takeda N; Nakamura S; Endo Y; Okuyama M; Miura K; Iida H; Kawade M
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):131-47. PubMed ID: 7044842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.